Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review.
Airoldi M, Amadori D, Barni S, Cinieri S, De Placido S, Di Leo A, Gennari A, Iacobelli S, Ionta MT, Lorusso V, Lotrionte M, Marchetti P, Mattioli R, Minotti G, Pronzato P, Rosti G, Tondini CA, Veronesi A. Airoldi M, et al. Among authors: lotrionte m. Tumori. 2011 Nov-Dec;97(6):690-2. doi: 10.1177/030089161109700602. Tumori. 2011. PMID: 22322832 Review.
Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
Lotrionte M, Palazzoni G, Natali R, Comerci G, Abbate A, Di Persio S, Biondi-Zoccai GG. Lotrionte M, et al. Int J Cardiol. 2009 Jun 12;135(1):72-7. doi: 10.1016/j.ijcard.2008.03.036. Epub 2008 Jun 24. Int J Cardiol. 2009. PMID: 18572266 Clinical Trial.
Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
Lotrionte M, Palazzoni G, Abbate A, De Marco E, Mezzaroma E, Di Persio S, Frati G, Loperfido F, Biondi-Zoccai G. Lotrionte M, et al. Int J Cardiol. 2013 Aug 10;167(3):1055-7. doi: 10.1016/j.ijcard.2012.10.079. Epub 2012 Nov 20. Int J Cardiol. 2013. PMID: 23174173 Clinical Trial. No abstract available.
Safety of drug-coated stents.
Biondi-Zoccai GG, Moretti C, Lotrionte M, Sheiban I. Biondi-Zoccai GG, et al. Among authors: lotrionte m. Expert Opin Drug Saf. 2008 Sep;7(5):597-606. doi: 10.1517/14740338.7.5.597. Expert Opin Drug Saf. 2008. PMID: 18759712 Review.
Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study.
Galiuto L, Lotrionte M, Crea F, Anselmi A, Biondi-Zoccai GG, De Giorgio F, Baldi A, Baldi F, Possati G, Gaudino M, Vetrovec GW, Abbate A. Galiuto L, et al. Among authors: lotrionte m. Heart. 2006 Feb;92(2):208-12. doi: 10.1136/hrt.2005.062422. Epub 2005 May 20. Heart. 2006. PMID: 15908482 Free PMC article.
57 results